259 related articles for article (PubMed ID: 28165586)
21. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.
Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904
[TBL] [Abstract][Full Text] [Related]
22. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
[TBL] [Abstract][Full Text] [Related]
23. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation.
Shimizu T; Hanasawa K; Sato K; Umeki M; Koga N; Naganuma T; Sato S; Shimonishi T; Ikeda T; Matsuno N; Ono S; Saitoh H; Satoh K; Otani Y; Endo Y; Eguchi Y; Tani T;
Langenbecks Arch Surg; 2009 Mar; 394(2):303-11. PubMed ID: 18685861
[TBL] [Abstract][Full Text] [Related]
24. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
Tojimbara T; Sato S; Nakajima I; Fuchinoue S; Akiba T; Teraoka S
Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
[TBL] [Abstract][Full Text] [Related]
25. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
[TBL] [Abstract][Full Text] [Related]
26. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
27. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
28. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
[TBL] [Abstract][Full Text] [Related]
29. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
[TBL] [Abstract][Full Text] [Related]
30. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
[TBL] [Abstract][Full Text] [Related]
31. Modulation by Polymyxin-B Hemoperfusion of Inflammatory Response Related to Severe Peritonitis.
Coudroy R; Payen D; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Collange O; Dewitte A; Martin-Lefevre L; Jabaudon M; Kerforne T; Ferrandière M; Kipnis E; Vela C; Chevalier S; Mallat J; Charreau S; Lecron JC; Robert R;
Shock; 2017 Jan; 47(1):93-99. PubMed ID: 27984535
[TBL] [Abstract][Full Text] [Related]
32. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
[TBL] [Abstract][Full Text] [Related]
33. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
Maekawa H; Negishi K
Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
[TBL] [Abstract][Full Text] [Related]
35. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients.
Takeyama N; Noguchi H; Hirakawa A; Kano H; Morino K; Obata T; Sakamoto T; Tamai F; Ishikura H; Kase Y; Kobayashi M; Naka T; Takahashi Y;
Blood Purif; 2012; 33(4):252-6. PubMed ID: 22472324
[TBL] [Abstract][Full Text] [Related]
36. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
[TBL] [Abstract][Full Text] [Related]
38. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
[TBL] [Abstract][Full Text] [Related]
39. [A study on the mechanism of enhanced diuresis following direct hemoperfusion with polymyxin B-immobilized fiber].
Terawaki H; Kasai K; Kobayashi H; Hirano K; Hamaguchi A; Kase Y; Horiguchi T; Yokoyama K; Yamamoto H; Nakayama M; Kawaguchi Y; Hosoya T
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):359-64. PubMed ID: 10998916
[TBL] [Abstract][Full Text] [Related]
40. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
Ishizuka M; Tago K; Kubota K
Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]